Voting Rights Announcements | 18 September 2009 17:15
STRATEC Biomedical Systems AG / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share)
18.09.2009
Dissemination of a Voting Rights announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Threadneedle Asset Management Holdings Limited, London, UK, has notified us
pursuant to § 21 sec. 1 WpHG on 16 September 2009, that on 14 September
2009 the share of voting rights in STRATEC Biomedical Systems AG,
Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 10% and
that the percentage of voting rights on that day amounted to 10.016%
(1,145,955 shares). These voting rights are in their entirety attributable
to Threadneedle Asset Management Holdings Limited pursuant to § 22 para. 1
sent. 1 No. 6, sent. 2 and sent. 3 WpHG. These voting rights are held
directly by Threadneedle Investment Funds ICVC and other funds.
Threadneedle Asset Management Holdings SARL, London, UK, has notified us
pursuant to § 21 sec. 1 WpHG on 16 September 2009, that on 14 September
2009 the share of voting rights in STRATEC Biomedical Systems AG,
Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 10% and
that the percentage of voting rights on that day amounted to 10.016%
(1,145,955 shares). These voting rights are in their entirety attributable
to Threadneedle Asset Management Holdings SARL pursuant to § 22 para. 1
sent. 1 No. 6, sent. 2 and sent. 3 WpHG. These voting rights are held
directly by Threadneedle Investment Funds ICVC and other funds.
Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us
pursuant to § 21 sec. 1 WpHG on 16 September 2009, that on 14 September
2009 the share of voting rights in STRATEC Biomedical Systems AG,
Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 10% and
that the percentage of voting rights on that day amounted to 10.016%
(1,145,955 shares). These voting rights are in their entirety attributable
to Ameriprise Financial, Inc. pursuant to § 22 para. 1 sent. 1 No. 6, sent.
2 and sent. 3 WpHG. These voting rights are held directly by Threadneedle
Investment Funds ICVC and other funds.
Ameriprise Financial Inc. is the parent company of Threadneedle Asset
Management Holdings SARL which is the parent company of Threadneedle Asset
Management Holdings Limited.
18.09.2009 Financial News transmitted by DGAP
---------------------------------------------------------------------------
Language: English
Company: STRATEC Biomedical Systems AG
Gewerbestraße 37
75217 Birkenfeld
Deutschland
Internet: www.stratec-biomedical.de
End of News DGAP News-Service
---------------------------------------------------------------------------